LACUESTA, G.; LEE, J. K. The Evidence and Clinical Rationale for the Use of JAK Inhibitors in the Management of AD . Canadian Allergy & Immunology Today, Toronto, Canada, v. 2, n. s11, p. 3–11, 2022. DOI: 10.58931/cait.2022.2s1148. Disponível em: https://canadianallergyandimmunologytoday.com/article/view/2-s11-lacuesta_and_lee. Acesso em: 23 nov. 2024.